Study title: Double blind cross-over study comparing the effects of two dose regimens of cetirizine (1 tablet of 10 mg od and 1 tablet of 5 mg bid during 3 days) on the histamine-induced wheal and flare reaction in 6 to 12 years old children
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Immune System Diseases | |||||
| Brands: | |||||
| MAH holders: | |||||
| Assessment: | |||||
| Active substance: CETIRIZINE | |||||
| ATC code: | |||||
| Document link: A168 - Cetirizine - RRCE92E2507.pdf | |||||
| Document date: 2011-11-28 | |||||
| Study number: RRCE92E2507 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | - | |